Allergan Recent Selloff 'Very Much Overdone,' Says JPMorgan
June 19, 2019 at 10:07 AM EDT
With Allergan shares down 14% over the last 30 days, JPMorgan analyst Chris Schott calls the recent selloff "very much overdone."
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.